Clint Eastwood takes on medical company over diabetes patents
27-07-2018
Randy Miramontez / Shutterstock.com
A judge has dismissed actor Clint Eastwood’s motion to gain ownership over two diabetes patents currently assigned to Molecular Defenses Corporation (MDC).
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Clint Eastwood, Molecular Defenses Corporation, 1988 Clinton Eastwood Trust, diabetes, glutathione, antioxidants, Antioxidant Pharmaceuticals Corporation
